Cargando…

Healthy cardiac myocytes can decrease sympathetic hyperexcitability in the early stages of hypertension

Sympathetic neurons are powerful drivers of cardiac excitability. In the early stages of hypertension, sympathetic hyperactivity is underpinned by down regulation of M current and increased activity of Cav(2.2) that is associated with greater intracellular calcium transients and enhanced neurotransm...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Harvey, Liu, Kun, Li, Ni, Li, Dan, Paterson, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386373/
https://www.ncbi.nlm.nih.gov/pubmed/35989710
http://dx.doi.org/10.3389/fnsyn.2022.949150
_version_ 1784769795134062592
author Davis, Harvey
Liu, Kun
Li, Ni
Li, Dan
Paterson, David J.
author_facet Davis, Harvey
Liu, Kun
Li, Ni
Li, Dan
Paterson, David J.
author_sort Davis, Harvey
collection PubMed
description Sympathetic neurons are powerful drivers of cardiac excitability. In the early stages of hypertension, sympathetic hyperactivity is underpinned by down regulation of M current and increased activity of Cav(2.2) that is associated with greater intracellular calcium transients and enhanced neurotransmission. Emerging evidence suggests that retrograde signaling from the myocyte itself can modulate synaptic plasticity. Here we tested the hypothesis that cross culturing healthy myocytes onto diseased stellate neurons could influence sympathetic excitability. We employed neuronal mono-cultures, co-cultures of neonatal ventricular myocytes and sympathetic stellate neurons, and mono-cultures of sympathetic neurons with media conditioned by myocytes from normal (Wistar) and pre-hypertensive (SHR) rats, which have heightened sympathetic responsiveness. Neuronal firing properties were measured by current-clamp as a proxy for neuronal excitability. SHR neurons had a maximum higher firing rate, and reduced rheobase compared to Wistar neurons. There was no difference in firing rate or other biophysical properties in Wistar neurons when they were co-cultured with healthy myocytes. However, the firing rate decreased, phenocopying the Wistar response when either healthy myocytes or media in which healthy myocytes were grown was cross-cultured with SHR neurons. This supports the idea of a paracrine signaling pathway from the healthy myocyte to the diseased neuron, which can act as a modulator of sympathetic excitability.
format Online
Article
Text
id pubmed-9386373
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93863732022-08-19 Healthy cardiac myocytes can decrease sympathetic hyperexcitability in the early stages of hypertension Davis, Harvey Liu, Kun Li, Ni Li, Dan Paterson, David J. Front Synaptic Neurosci Neuroscience Sympathetic neurons are powerful drivers of cardiac excitability. In the early stages of hypertension, sympathetic hyperactivity is underpinned by down regulation of M current and increased activity of Cav(2.2) that is associated with greater intracellular calcium transients and enhanced neurotransmission. Emerging evidence suggests that retrograde signaling from the myocyte itself can modulate synaptic plasticity. Here we tested the hypothesis that cross culturing healthy myocytes onto diseased stellate neurons could influence sympathetic excitability. We employed neuronal mono-cultures, co-cultures of neonatal ventricular myocytes and sympathetic stellate neurons, and mono-cultures of sympathetic neurons with media conditioned by myocytes from normal (Wistar) and pre-hypertensive (SHR) rats, which have heightened sympathetic responsiveness. Neuronal firing properties were measured by current-clamp as a proxy for neuronal excitability. SHR neurons had a maximum higher firing rate, and reduced rheobase compared to Wistar neurons. There was no difference in firing rate or other biophysical properties in Wistar neurons when they were co-cultured with healthy myocytes. However, the firing rate decreased, phenocopying the Wistar response when either healthy myocytes or media in which healthy myocytes were grown was cross-cultured with SHR neurons. This supports the idea of a paracrine signaling pathway from the healthy myocyte to the diseased neuron, which can act as a modulator of sympathetic excitability. Frontiers Media S.A. 2022-08-04 /pmc/articles/PMC9386373/ /pubmed/35989710 http://dx.doi.org/10.3389/fnsyn.2022.949150 Text en Copyright © 2022 Davis, Liu, Li, Li and Paterson. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Davis, Harvey
Liu, Kun
Li, Ni
Li, Dan
Paterson, David J.
Healthy cardiac myocytes can decrease sympathetic hyperexcitability in the early stages of hypertension
title Healthy cardiac myocytes can decrease sympathetic hyperexcitability in the early stages of hypertension
title_full Healthy cardiac myocytes can decrease sympathetic hyperexcitability in the early stages of hypertension
title_fullStr Healthy cardiac myocytes can decrease sympathetic hyperexcitability in the early stages of hypertension
title_full_unstemmed Healthy cardiac myocytes can decrease sympathetic hyperexcitability in the early stages of hypertension
title_short Healthy cardiac myocytes can decrease sympathetic hyperexcitability in the early stages of hypertension
title_sort healthy cardiac myocytes can decrease sympathetic hyperexcitability in the early stages of hypertension
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386373/
https://www.ncbi.nlm.nih.gov/pubmed/35989710
http://dx.doi.org/10.3389/fnsyn.2022.949150
work_keys_str_mv AT davisharvey healthycardiacmyocytescandecreasesympathetichyperexcitabilityintheearlystagesofhypertension
AT liukun healthycardiacmyocytescandecreasesympathetichyperexcitabilityintheearlystagesofhypertension
AT lini healthycardiacmyocytescandecreasesympathetichyperexcitabilityintheearlystagesofhypertension
AT lidan healthycardiacmyocytescandecreasesympathetichyperexcitabilityintheearlystagesofhypertension
AT patersondavidj healthycardiacmyocytescandecreasesympathetichyperexcitabilityintheearlystagesofhypertension